MongoDB, Inc. (MDB) has become one of the most debated names in enterprise software, and $500 has emerged as a natural focal point. The figure is both a psychological milestone and a level several Wall Street firms have now put in their price-target ranges. With shares having rebounded sharply from their 52-week low near $215 to a recent close around $410, the gap to $500 looks increasingly bridgeable, yet still meaningful enough to require a genuine catalyst rather than a routine rally.
MongoDB is a leading developer data platform whose flagship offering, Atlas, is a fully managed cloud database service that accounted for roughly 73% of revenue in its most recent reported quarter. The company has shifted from a downloadable open-source tool into a cloud-based data platform that increasingly supports artificial intelligence (AI) workloads and modern applications. Trailing twelve-month revenue reached about $2.78 billion, and the most recent quarter delivered revenue of approximately $771.8 million, up roughly 30% year over year, with net income turning positive. The company carries about $2.4 billion in cash and minimal debt, giving it a clean balance sheet, and its market capitalization stands near $33 billion. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The core bull case rests on AI and data modernization. MongoDB has argued that the shift toward AI applications and token-based consumption increases demand for flexible, document-oriented databases that can handle unstructured data. Enterprise momentum has been a bright spot, with the number of customers spending $100,000 or more annually climbing to roughly 2,999 in the latest quarter. If Atlas growth holds in the high-20% range and enterprises continue consolidating workloads onto the platform, revenue expansion could support further multiple expansion and a push toward $500.
Sentiment on Wall Street has also turned notably more constructive. Recent analyst actions include price-target increases from firms such as BMO Capital to $500, Evercore ISI to $525, Bank of America to $540, Citi to $545, and Guggenheim to $560. The broader consensus rating is a Buy, with an average analyst price target in the mid-$400s—suggesting many professionals already see upside beyond the current price, even if not all extend to $500. From what I see, this cluster of targets adds meaningful conviction.
The most obvious obstacle is valuation. Even after a period of improving profitability, MongoDB trades at a forward price-to-earnings (P/E) ratio well above the broader market—a premium that leaves little room for execution missteps. The company's consumption-based pricing model, while attractive in an AI boom, also makes revenue sensitive to fluctuations in enterprise IT budgets and can decelerate quickly when customers optimize spending.
Competition remains intense. Hyperscalers such as Amazon Web Services, Microsoft Azure, and Google Cloud offer their own database services, and MongoDB competes with other data platforms for the same modern-stack budgets. Insider selling has also surfaced at times, a factor some investors read cautiously even when it reflects routine diversification. Finally, the stock's elevated beta—meaning it tends to move more sharply than the market—adds volatility risk around any disappointment in guidance.
From a technical perspective, the most relevant resistance level is the 52-week high near $473, which sits just below the $500 target. A decisive close above that zone would clear the way toward $500, while a failure to hold recent support around the $380–$410 area could signal fading momentum. It is worth noting that MongoDB traded above $500 as recently as its all-time peak near $590 in late 2021, so the $500 mark is not unprecedented territory—it is a recovery milestone rather than an entirely new frontier. I’m watching this closely as the stock approaches that resistance.
A move to $500 for MongoDB is realistic but far from assured. The strongest support comes from accelerating Atlas growth, a strengthening enterprise customer base, and a cluster of analyst targets at or above that level. The primary risks are a demanding valuation, a consumption model vulnerable to spending shifts, and stiff competition. Investors should watch Atlas revenue growth, net revenue retention, enterprise customer additions, and whether the stock can break through its 52-week high near $473. A sustained push above that resistance would meaningfully improve the odds that $500 becomes reachable, while any guidance disappointment could quickly derail the rally.
In my research process, I often turn to Tickeron’s AI Daily Buy/Sell Signals to monitor momentum in names like MDB. The tool uses artificial intelligence to scan thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on technical behavior and market conditions. It offers a practical way to track developing trends without relying solely on manual chart review.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
On October 01, 2026, the Stochastic Oscillator for MDB moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 60 instances where the indicator left the oversold zone. In 47 of the 60 cases the stock moved higher in the following days. This puts the odds of a move higher at over 78%.
Following a +0.77% 3-day Advance, the price is estimated to grow further. Considering data from situations where MDB advanced for three days, in 235 of 300 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
The Momentum Indicator moved below the 0 level on September 28, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MDB as a result. In 63 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 73%.
The Moving Average Convergence Divergence Histogram (MACD) for MDB turned negative on September 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 32 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 74%.
MDB moved below its 50-day moving average on September 28, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for MDB crossed bearishly below the 50-day moving average on October 01, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 75%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MDB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
MDB broke above its upper Bollinger Band on September 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for MDB entered a downward trend on October 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. MDB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 68 (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 88 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 93 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.050) is normal, around the industry mean (17.861). P/E Ratio (471.380) is within average values for comparable stocks, (159.605). Projected Growth (PEG Ratio) (1.654) is also within normal values, averaging (3.648). Dividend Yield (0.000) settles around the average of (0.004) among similar stocks. P/S Ratio (11.025) is also within normal values, averaging (104.490).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MDB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a developer of MongoDB database
Industry ComputerCommunications